Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases II
Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 904 - 904
Опубликована: Апрель 8, 2025
Hepatobiliary
diseases,
including
liver
fibrosis,
cirrhosis,
hepatocellular
carcinoma
(HCC),
and
cholestatic
disorders,
pose
significant
global
health
challenges
due
to
their
complex
pathogenesis
limited
treatment
options
[...]
Язык: Английский
Oxidative stress modulation in alcohol-related liver disease: From chinese botanical drugs to exercise-based interventions
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 25, 2025
Alcohol-related
liver
disease
(ALD)
is
a
chronic
injury
caused
by
long-term
excessive
alcohol
consumption,
with
complex
and
multifaceted
pathological
mechanisms.
Research
indicates
that
oxidative
stress
(OS),
inflammatory
responses,
lipid
metabolic
disturbances
induced
its
metabolites
are
primary
contributors
to
hepatocyte
injury,
positioning
OS
as
key
target
in
ALD
treatment.
The
main
non-pharmacological
treatment
for
abstinence,
while
medical
primarily
relies
on
Western
pharmacological
interventions.
However,
recent
research
has
increasingly
highlighted
the
potential
of
Chinese
botanical
drugs
improving
histological
features
modulating
signaling
pathways
associated
ALD,
underscoring
therapeutic
traditional
herb
medicine.
Despite
these
promising
findings,
precise
mechanisms
effects
extracts
remain
incompletely
understood,
side
must
be
considered.
Therefore,
comprehensive
analysis
herbal
essential
optimize
clinical
administration
ensure
safe,
effective
This
review
focuses
central
theme,
categorizing
into
six
major
groups—flavonoids,
polyphenols,
terpenoids,
alkaloids,
saponins,
anthraquinones—all
widely
used
provides
an
overview
their
characteristics
actions
context
offering
insights
regulation
exploring
treatments
ALD.
Notably,
physical
exercise
shares
overlapping
regulating
OS.
Combining
two
strategies
could
offer
integrative
though
further
needed
confirm
synergistic
benefits
applications.
Язык: Английский
Artificial intelligence in imaging for liver disease diagnosis
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Апрель 25, 2025
Liver
diseases,
including
hepatitis,
non-alcoholic
fatty
liver
disease
(NAFLD),
cirrhosis,
and
hepatocellular
carcinoma
(HCC),
remain
a
major
global
health
concern,
with
early
accurate
diagnosis
being
essential
for
effective
management.
Imaging
modalities
such
as
ultrasound
(US),
computed
tomography
(CT),
magnetic
resonance
imaging
(MRI)
play
crucial
role
in
non-invasive
diagnosis,
but
their
sensitivity
diagnostic
accuracy
can
be
limited.
Recent
advancements
artificial
intelligence
(AI)
have
improved
imaging-based
assessment
by
enhancing
pattern
recognition,
automating
fibrosis
steatosis
quantification,
aiding
HCC
detection.
AI-driven
techniques
shown
promise
staging
through
US,
CT,
MRI,
elastography,
reducing
the
reliance
on
invasive
biopsy.
For
steatosis,
AI-assisted
methods
grading
consistency,
while
detection
characterization,
AI
models
enhanced
lesion
identification,
classification,
risk
stratification
across
modalities.
The
growing
integration
of
into
is
reshaping
workflows
has
potential
to
improve
accuracy,
efficiency,
clinical
decision-making.
This
review
provides
an
overview
applications
imaging,
focusing
utility
implications
future
diagnosis.
Язык: Английский